A Study to See How BIIB122 Works in the Human Body, and to Evaluate it's Safety, and Tolerability in Healthy Adult Japanese, Chinese, and Caucasian Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 17, 2022

Primary Completion Date

September 7, 2022

Study Completion Date

September 7, 2022

Conditions

Healthy Volunteer

Interventions

DRUG

BIIB122

Administered as specified in the treatment arm.

Trial Locations (1)

Anaheim Clinical Trials, LLC, Anaheim